As price transparency data transforms payer and provider negotiations, we examine how Milliman Transparent can help stakeholders develop targets and strategy.
We shed some light on the differences between using CMS’s Medicare fee schedules and Milliman Global Relative Value Units.
Milliman Transparent can support self-funded employers with analytics based on price transparency data to enhance their benefit offerings and fulfill their obligations as fiduciaries.
We discuss real-world examples and highlight key questions to show how Milliman Transparent contains the analytics that healthcare payers need to succeed in contracting.
Improving provider network identification could yield improved interpretation of price transparency data and processing burden.
Price transparency data unlocks a new era of healthcare analytics
New regulation aims to increase price transparency at hospitals, but challenges exist when extracting useful competitive information from their machine-readable files.
This report is the first in a series of updates Milliman will publish on the implementation trends for new regulations for hospital price transparency.
Regulations that took effect January 1, 2021 introduced a new level of price transparency in the U.S. healthcare system.
Recent changes in health plan and hospital transparency rules have potential to expand transparency to commercial market.